Revium Rx (RVRC) Accounts Payables (2024 - 2025)
Revium Rx (RVRC) reported Accounts Payables of $163000.0 for Q4 2025, up 14.79% on a YoY basis from $142000.0 in Q4 2024, and up 14.79% sequentially from $142000.0 in Q4 2024.
Revium Rx (RVRC) Accounts Payables (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Accounts Payables data on file, last reported at $163000.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables rose 14.79% year-over-year to $163000.0; the trailing twelve-month figure through Dec 2025 stood at $163000.0 (up 14.79% YoY), and the FY2025 full-year result was $163000.0, up 14.79% from the prior year.
- Accounts Payables grew to $163000.0 in Q4 2025, from $142000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $163000.0 in Q4 2025 to a low of $142000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.72 Bn | 24.41 Bn | 662.02 Mn | 40.66 Mn |
| 2 | BrightSpring Health Services | 14.65 Bn | 13.75 Bn | 482.22 Mn | 1.09 Bn |
| 3 | Healthequity | 8.27 Bn | 8.00 Bn | 256.31 Mn | 14.22 Mn |
| 4 | 10x Genomics | 5.90 Bn | 5.36 Bn | 106.18 Mn | 17.43 Mn |
| 5 | Hinge Health | 5.88 Bn | 5.56 Bn | 154.23 Mn | 69.48 Mn |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | 163.00 Mn |
| 7 | Waystar Holding | 4.44 Bn | 4.38 Bn | 216.84 Mn | 58.80 Mn |
| 8 | Doximity | 3.94 Bn | 3.19 Bn | 125.97 Mn | 4.01 Mn |
| 9 | Privia Health | 3.16 Bn | 2.74 Bn | - | 80.56 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 163,000.00 |
| Dec 31, 2024 | 142,000.00 |